ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,169, issued on Feb. 17, was assigned to Covidien LP (Mansfield, Mass.).
"Determining changes to autoregulation" was invented by Paul S. Addison (Edinburgh, Great Britain), Dean Montgomery (Edinburgh, Great Britain) and Andre Antunes (Edinburgh, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "In some examples, a device includes a memory configured to store a first relationship between a blood pressure and another physiological parameter of a patient, the first relationship being indicative of cerebral autoregulation of the patient. The device also includes processing circuitry configured to receive first and second signals indicative of ...